Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluticasone propionate is a synthetic glucocorticoid steroid medication used primarily for its anti-inflammatory effects. It is available in various formulations including inhalers (for asthma and chronic obstructive pulmonary disease), nasal sprays (for allergic rhinitis and nasal polyps), and topical creams (for skin conditions such as eczema and psoriasis). The drug works by activating glucocorticoid receptors to suppress inflammation through multiple pathways. It was first patented in 1980 and approved for medical use in 1990. Fluticasone propionate is widely prescribed globally and is available as both branded and generic products[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluticasone propionate.